Filing Details
- Accession Number:
- 0001140361-17-019306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-10 15:23:58
- Reporting Period:
- 2017-04-28
- Filing Date:
- 2017-05-10
- Accepted Time:
- 2017-05-10 15:23:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514980 | Brian Mueller | 105 Digital Drive Novato CA 94949 | Svp, Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-04-28 | 270 | $70.30 | 18,350 | No | 5 | A | Direct | |
Common Stock | Disposition | 2017-05-08 | 4,882 | $91.17 | 13,468 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-08 | 2,600 | $21.51 | 16,068 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-08 | 2,600 | $93.17 | 13,468 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2017-05-08 | 2,600 | $0.00 | 2,600 | $21.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,671 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.
- All shares were sold at the same price.
- Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.